Please use this identifier to cite or link to this item:
|Title:||Infection probability score : a predictor of clostridium difficile-associated disease onset in patients with haematological malignancy||Authors:||Apostolopoulou, Eleni A.
Elefsiniotis, Ioannis S.
|Major Field of Science:||Medical and Health Sciences||Field Category:||Clinical Medicine||Keywords:||APACHE II;Clostridium difficile-associated disease;Healthcare-associated infections;Hematology;Infection probability score;KARNOFSKY||Issue Date:||Dec-2011||Source:||European Journal of Oncology Nursing, 2011, vol. 15, no. 5, pp. 404-409||Volume:||15||Issue:||5||Start page:||404||End page:||409||Journal:||European Journal of Oncology Nursing||Abstract:||Purpose: to assess the predictive power of three systems: Infection Probability Score, APACHE II and KARNOFSKY score for the onset of Clostridium difficile-associated disease (CDAD) in hematology-oncology patients. Methods and sample: A retrospective pilot surveillance survey was conducted in the hematology unit of a general hospital in Greece. Data were collected by using an anonymous standardised case-record form. The sample consisted of 102 hospitalized patients. Results: The majority of the patients (33.3%) suffered from acute myeloid leukemia. The cumulative incidence of CDAD was 10.8% and the incidence rate of C difficile associated diarrhea was 5 per 1000 patient-days (14.2 per 1000 patient-days at risk). Patients with CDAD had twofold higher time of mean length of hospital stay compared with patients without CDAD (38.82 ± 23.88 vs 19.45 ± 14.56 days). Additionally patients with CDAD had received a greater number of different antibiotics compared to those without CDAD (5.18 ± 1.99 vs 2.54 ± 2.13), suffered from diabetes, from non Hodgkin's lymphoma, had a statistically significant higher duration of neutropenia ≥3 days and had received antifungal treatment. The best cutoff value of IPS for the prediction of CDAD was 13 with a sensitivity of 45.5% and a specificity of 82.4%. Conclusions: IPS is an early diagnostic test for CDAD detection.||ISSN:||1532-2122||DOI:||10.1016/j.ejon.2010.11.002||Rights:||© Elsevier||Type:||Article||Affiliation :||Cyprus University of Technology
University of Athens
Halkida General Hospital
|Appears in Collections:||Άρθρα/Articles|
checked on Nov 26, 2020
WEB OF SCIENCETM
checked on Nov 27, 2020
Page view(s) 10214
checked on Nov 28, 2020
Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.